166 related articles for article (PubMed ID: 28992060)
1. Heterozygosity of mitogen-activated protein kinase organizer 1 ameliorates diabetic nephropathy and suppresses epithelial-to-mesenchymal transition-like changes in db/db mice.
Loeffler I; Liebisch M; Daniel C; Amann K; Wolf G
Nephrol Dial Transplant; 2017 Dec; 32(12):2017-2034. PubMed ID: 28992060
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycated end-products affect HIF-transcriptional activity in renal cells.
Bondeva T; Heinzig J; Ruhe C; Wolf G
Mol Endocrinol; 2013 Nov; 27(11):1918-33. PubMed ID: 24030251
[TBL] [Abstract][Full Text] [Related]
3. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
4. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling.
Zhang X; Liang D; Fan J; Lian X; Zhao Y; Wang X; Chi ZH; Zhang P
Biol Trace Elem Res; 2016 Oct; 173(2):372-83. PubMed ID: 26956696
[TBL] [Abstract][Full Text] [Related]
5. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
[TBL] [Abstract][Full Text] [Related]
6. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
Kang MK; Park SH; Choi YJ; Shin D; Kang YH
J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II differentially regulates Morg1 expression in kidney cells.
Bondeva T; Heinzig J; Franke S; Wolf G
Am J Nephrol; 2012; 35(5):442-55. PubMed ID: 22555025
[TBL] [Abstract][Full Text] [Related]
8. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.
Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M
Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805
[TBL] [Abstract][Full Text] [Related]
9. Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.
Du L; Qian X; Li Y; Li XZ; He LL; Xu L; Liu YQ; Li CC; Ma P; Shu FL; Lu Q; Yin XX
Acta Pharmacol Sin; 2021 Feb; 42(2):242-251. PubMed ID: 32555442
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy.
Lu Q; Chen YB; Yang H; Wang WW; Li CC; Wang L; Wang J; Du L; Yin XX
Acta Pharmacol Sin; 2019 Dec; 40(12):1555-1567. PubMed ID: 31235817
[TBL] [Abstract][Full Text] [Related]
11. Morg1(+/-) heterozygous mice are protected from experimentally induced focal cerebral ischemia.
Stahr A; Frahm C; Kretz A; Bondeva T; Witte OW; Wolf G
Brain Res; 2012 Oct; 1482():22-31. PubMed ID: 22982595
[TBL] [Abstract][Full Text] [Related]
12. Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway.
Sun X; Huang K; Haiming X; Lin Z; Yang Y; Zhang M; Liu P; Huang H
Clin Sci (Lond); 2020 Jul; 134(13):1573-1592. PubMed ID: 32558900
[TBL] [Abstract][Full Text] [Related]
13. Morg1 heterozygous deficiency ameliorates hypoxia-induced acute renal injury.
Loeffler I; Wolf G
Am J Physiol Renal Physiol; 2015 Mar; 308(6):F511-21. PubMed ID: 25550320
[TBL] [Abstract][Full Text] [Related]
14. MORG1-A Negative Modulator of Renal Lipid Metabolism in Murine Diabetes.
Jankowski E; Wulf S; Ziller N; Wolf G; Loeffler I
Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052710
[TBL] [Abstract][Full Text] [Related]
15. MORG1
Bondeva T; Schindler C; Schindler K; Wolf G
BMC Nephrol; 2018 Feb; 19(1):29. PubMed ID: 29402223
[TBL] [Abstract][Full Text] [Related]
16. Morg1 heterozygous mice are protected from acute renal ischemia-reperfusion injury.
Hammerschmidt E; Loeffler I; Wolf G
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1273-87. PubMed ID: 19726548
[TBL] [Abstract][Full Text] [Related]
17. The PKM2 activator TEPP-46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF-1α accumulation.
Liu H; Takagaki Y; Kumagai A; Kanasaki K; Koya D
J Diabetes Investig; 2021 May; 12(5):697-709. PubMed ID: 33314682
[TBL] [Abstract][Full Text] [Related]
18. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy.
Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H
Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104
[TBL] [Abstract][Full Text] [Related]
19. Collagen VIII influences epithelial phenotypic changes in experimental diabetic nephropathy.
Loeffler I; Liebisch M; Wolf G
Am J Physiol Renal Physiol; 2012 Sep; 303(5):F733-45. PubMed ID: 22759394
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease.
Hu Y; Tang W; Liu W; Hu Z; Pan C
Drug Des Devel Ther; 2022; 16():1605-1620. PubMed ID: 35669284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
